[Journal logo]

Volume 69 
Part 1 
Pages 93-100  
January 2013  

Received 23 November 2012
Accepted 30 November 2012
Online 15 December 2012

Five pseudopolymorphs of 6-amino-2-thiouracil: absence of N-H...S hydrogen bonds

aInstitut für Organische Chemie und Chemische Biologie, Goethe-Universität Frankfurt, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany, and bInstitut für Anorganische und Analytische Chemie, Goethe-Universität Frankfurt, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany
Correspondence e-mail: bolte@chemie.uni-frankfurt.de

In order to study the preferred hydrogen-bonding pattern of 6-amino-2-thiouracil, C4H5N3OS, (I), crystallization experiments yielded five different pseudopolymorphs of (I), namely the dimethylformamide disolvate, C4H5N3OS·2C3H7NO, (Ia), the dimethylacetamide monosolvate, C4H5N3OS·C4H9NO, (Ib), the dimethylacetamide sesquisolvate, C4H5N3OS·1.5C4H9NO, (Ic), and two different 1-methylpyrrolidin-2-one sesquisolvates, C4H5N3OS·1.5C5H9NO, (Id) and (Ie). All structures contain R21(6) N-H...O hydrogen-bond motifs. In the latter four structures, additional R22(8) N-H...O hydrogen-bond motifs are present stabilizing homodimers of (I). No type of hydrogen bond other than N-H...O is observed. According to a search of the Cambridge Structural Database, most 2-thiouracil derivatives form homodimers stabilized by an R22(8) hydrogen-bonding pattern, with (i) only N-H...O, (ii) only N-H...S or (iii) alternating pairs of N-H...O and N-H...S hydrogen bonds.

Comment

Thio-analogues of the nucleobases play an important role in biological processes. For example, 2-thiouracil was found to be part of the anticodon of transfer RNAs. For six-membered cyclic compounds with hydrogen-bonding sites similar to 2-thiouracil, the R22(8) hydrogen-bonding pattern (Bernstein et al., 1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]) turned out to be preferred for N-H...O or N-H...S interactions (Tutughamiarso & Egert, 2011[Tutughamiarso, M. & Egert, E. (2011). Acta Cryst. C67, o439-o445.]). Moreover, a Cambridge Structural Database substructure search (CSD, Version 5.33, November 2011 plus four updates; Allen, 2002[Allen, F. H. (2002). Acta Cryst. B58, 380-388.]) revealed that for 2-thiouracil derivatives, N-H...S hydrogen bonds are solely observed within R22(8) motifs. Prompted by these results, we decided to crystallize 6-amino-2-thiouracil, (I), in order to analyze the effect of an additional NH2 donor group on the hydrogen-bonding pattern formed. 6-Amino-2-thiouracil shows anticorrosion and antifouling properties and can be used as an additive in marine anticorrosion paint (Tadros & Abd El Nabey, 2000[Tadros, A. B. & Abd El Nabey, B. A. (2000). Anti-Corros. Methods Mater. 47, 211-214.]). It exhibits antiviral activity (Romero et al., 1993[Romero, M. A., Sanchez, M. P., Quiros, M., Sanchez, F., Salas, J. M., Moreno, M. N. & Faure, R. (1993). Can. J. Chem. 71, 29-33.]) and is also an important precursor for the synthesis of compounds with various pharmacological properties, including anti-analgesic, anti-inflammatory (Alagarsamy et al., 2007[Alagarsamy, V., Vijayakumar, S. & Solomon, V. R. (2007). Biomed. Pharmacother. 61, 285-291.]; Youssif & Mohamed, 2008[Youssif, S. & Mohamed, S. F. (2008). Chem. Monthly, 139, 161-168.]; Abu-Hashem & Youssef, 2011[Abu-Hashem, A. A. & Youssef, M. M. (2011). Molecules, 16, 1956-1972.]), antibacterial, antifungal, antitumor and diuretic activity (Mohamed et al., 2007[Mohamed, N. R., El-Saidi, M. M. T., Alia, Y. M. & Elnagdib, M. H. (2007). Bioorg. Med. Chem. 15, 6227-6235.]; El-Gazzar

[Scheme 1]
& Hafez, 2009[El-Gazzar, A.-R. B. A. & Hafez, H. N. (2009). Bioorg. Med. Chem. 19, 3392-3397.]). Furthermore, it is used as a precursor for the synthesis of A3 adenosine receptor antagonists (Cosimelli et al., 2008[Cosimelli, B., Greco, G., Ehlardo, M., Novellino, E., Da Settimo, F., Taliani, S., La Motta, C., Bellandi, M., Tuccinardi, T., Martinelli, A., Ciampi, O., Trincavelli, M. L. & Martini, C. (2008). J. Med. Chem. 51, 1764-1770.]), as well as for inhibitors of DNA III polymerase (Wright & Brown, 1976[Wright, G. E. & Brown, N. C. (1976). Biochim. Biophys. Acta, 432, 37-48.]).

Crystallization experiments from different solvents yielded five new pseudopolymorphs of (I), i.e. the dimethylformamide (DMF) disolvate, (Ia), the dimethylacetamide (DMAC) monosolvate, (Ib), the dimethylacetamide sesquisolvate, (Ic), and two different 1-methylpyrrolidin-2-one (NMP) sesquisolvates, (Id) and (Ie).

Compound (Ia) crystallized in the triclinic space group P[\overline{1}] with two planar 6-amino-2-thiouracil molecules, A and B [r.m.s. deviations for all non-H atoms = 0.027 (for A) and 0.024 Å (for B)], and four DMF molecules, denoted W, X, Y, and Z, in the asymmetric unit (Fig. 1[link]). All molecules in the asymmetric unit lie in a common plane parallel to (11[\overline{1}]) (r.m.s. deviation for all non-H atoms = 0.086 Å). The molecules of (I) are connected by N-H...O hydrogen bonds (Table 2[link]) in an R21(6) pattern, forming chains running along [1[\overline{1}]0] (Fig. 2[link]). Linked by N-H...O hydrogen bonds to (I), the DMF molecules are located on both sides of the chains, respectively, with molecule A connected to DMF molecules W and X and molecule B to DMF molecules Y and Z.

The DMAC solvate (Ib) crystallized in the monoclinic space group P21/n. The asymmetric unit consists of one 6-amino-2-thiouracil (r.m.s. deviation for all non-H atoms = 0.017 Å) and one disordered DMAC molecule. The two molecules are connected by an R21(6) pattern of N-H...O hydrogen bonds (Table 3[link]) and are almost coplanar with each other (r.m.s. deviation = 0.088 Å for all non-H atoms; Fig. 3[link]). In the crystal packing, the 6-amino-2-thiouracil molecules show R22(8) motifs of N-H...O hydrogen-bonded homodimers. Connected by further N-H...O hydrogen bonds, these dimers assemble into a three-dimensional network with adjacent dimers enclosing a dihedral angle of 48.26 (3)° (Fig. 4[link]).

Compounds (Ic) and (Id) are isomorphous and crystallized in the orthorhombic space group Pca21. The asymmetric unit consists of two 6-amino-2-thiouracil molecules, A and B [r.m.s. deviations for all non-H atoms = 0.024 (for A) and 0.013 Å (for B) in (Ic), and 0.022 (for A) and 0.011 Å (for B) in (Id)], and three solvent molecules, denoted X, Y and Z (Figs. 5[link] and 6[link]). DMAC molecules X and Y in (Ic), as well as NMP molecules Y and Z in (Id), are disordered over two positions. The 6-amino-2-thiouracil molecules are connected to homodimers stabilized by an R22(8) pattern of N-H...O hydrogen bonds (Tables 4[link] and 5[link]). Adjacent dimers are connected by further N-H...O hydrogen bonds and enclose a dihedral angle of 47.3 (1)° in (Ic) and 50.7 (7)° in (Id). In addition, the molecules of (I) show R21(6) N-H...O interactions with the solvent molecules whereby molecule A is connected to X and molecule B to Z, respectively (Fig. 7[link]). Molecule B also forms an N-H...O hydrogen bond with solvent molecule Y. The crystal packing consists of zigzag-like chains of AB homodimers running along the a axis.

Pseudopolymorph (Ie) crystallized in the orthorhombic space group Pbca. The asymmetric unit consists of two 6-amino-2-thiouracil molecules, A and B [r.m.s. deviations for all non-H atoms = 0.020 (for A) and 0.011 Å (for B)], and three NMP molecules, denoted X, Y and Z (Fig. 8[link]). The molecules of (I) form homodimers stabilized by R22(8) N-H...O hydrogen bonds (Table 6[link]). Adjacent dimers are connected by N-H...O hydrogen bonds and enclose a dihedral angle of 51.6 (6)°. Both molecules A and B show additional R21(6) N-H...O interactions, with molecule A connected to molecule X and molecule B to Z, respectively (Fig. 9[link]). Molecule B also forms one N-H...O hydrogen bond with NMP molecule Y. In the crystal packing, the AB homodimers are arranged in a herringbone structure (Fig. 10[link]).

In the structures of these five pseudopolymorphs, two different types of N-H...O hydrogen-bonding patterns are observed. In all structures, R21(6) motifs are present, which are either formed between two molecules of (I) in (Ia) or between one molecule of (I) and one solvent molecule in (Ib), (Ic), (Id) and (Ie). In the latter four structures, additional R22(8) hydrogen-bond patterns between molecules of (I) are formed. In these five structures, the S atoms do not participate in any hydrogen-bonding interactions.

The hydrogen-bonding pattern formed by (I) was compared with other 2-thiouracil derivatives retrieved from the CSD. This search yielded a total number of 39 hits, of which 29 structures contain R22(8) motifs. Nine of these structures show R22(8) motifs with two N-H...O hydrogen bonds [refcodes FAJWES (Brewer et al., 1987[Brewer, A. D., Ferguson, G. & Parvez, M. (1987). Acta Cryst. C43, 144-147.]), FICBEY (Delage, H'Naifi & Goursolle, 1986[Delage, C., H'Naifi, A. & Goursolle, M. (1986). C. R. Seances Acad. Sci. Ser. II, 303, 1645.]), HEPMIY (Pastor et al., 1994[Pastor, A., Alajarin, R., Vaquero, J. J., Alvarez-Builla, J., Fau de Casa-Juana, M., Sunkel, C., Priego, J. G., Fonseca, I. & Sanz-Aparicio, J. (1994). Tetrahedron, 50, 8085-8098.]), MUYTIK (Ivanova & Spiteller, 2010[Ivanova, B. B. & Spiteller, M. (2010). Cryst. Growth Des. 10, 2470-2474.]), HAFLAC (Antoniadis et al., 2003[Antoniadis, C. D., Corban, G. J., Hadjikakou, S. K., Hadjiliadis, N., Kubicki, M., Warner, S. & Butler, I. S. (2003). Eur. J. Inorg. Chem. pp. 1635-1640.]), LACJIJ (Tashkhodzhaev et al., 2002[Tashkhodzhaev, B., Turgunov, K. K., Usmanova, B., Averkiev, B. B., Antipin, Y. M. & Shakhidoyatov, K. M. (2002). Zh. Strukt. Khim. (Russ. J. Struct. Chem.), 43, 944.]), EBAQOP (Balas et al., 2011[Balas, V. I., Verginadis, I. I., Geromichalos, G. D., Kourkoumelis, N., Male, L., Hursthouse, M. B., Repana, K. H., Yiannaki, E., Charalabopoulos, K., Bakas, T. & Hadjikakou, S. K. (2011). Eur. J. Med. Chem. 46, 2835-2844.]), and EBAQOP01 and DAYGUH (Kubicki et al., 2012[Kubicki, M., Owczarzak, A., Balas, V. I. & Hadjikakou, S. K. (2012). J. Coord. Chem. 65, 1107-1117.])] and 11 structures contain R22(8) motifs characterized by two N-H...S hydrogen bonds [FALWOF (Orzeszko et al., 2004[Orzeszko, B., Kazimierczuk, Z., Maurin, J. K., Laudy, A. E., Starosciak, B. J., Vilpo, J., Vilpo, L., Balzarini, J. & Orzeszko, A. (2004). Il Farmaco, 59, 929-937.]), FUWBOP (Medda et al., 2009[Medda, F., Russell, R. J. M., Higgins, M., McCarthy, A. R., Campbell, J., Slawin, A. M. Z., Lane, D. P., Lain, Y. & Westwood, N. J. (2009). J. Med. Chem. 52, 2673-2682.]), LOFDAL (Fonar et al., 1999[Fonar, M. S., Simonov, Y. A., Ganin, E. V., Yavolovskii, A. A. & Lyuboradzki, R. (1999). Kristallografiya (Russ.) (Crystallogr. Rep.), 44, 1076.]), MUGMIK (Matkovic-Calogovic et al., 2002[Matkovic-Calogovic, D., Besic, E. & Sankovic, K. (2002). Acta Cryst. C58, o568-o569.]), PABNAJ, PABNIR (Chierotti et al., 2010[Chierotti, M. R., Ferrero, L., Garino, N., Gobetto, R., Pellegrino, L., Braga, D., Grepioni, F. & Maini, L. (2010). Chem. Eur. J. 16, 4347-4358.]), QAYCID (Van Hecke et al., 2005[Van Hecke, K., Nockemann, P. & Van Meervelt, L. (2005). Z. Kristallogr. 220, 155.]), QEHSEB (Tiekink, 2001[Tiekink, E. R. T. (2001). Z. Kristallogr. 216, 122.]), ZZZGEO01 (Delage, H'Naifi, Goursolle & Carpy, 1986[Delage, C., H'Naifi, A., Goursolle, M. & Carpy, A. (1986). C. R. Seances Acad. Sci. Ser. II, 302, 219.]), and CALFUS and CALGAZ (Tutughamiarso & Egert, 2011[Tutughamiarso, M. & Egert, E. (2011). Acta Cryst. C67, o439-o445.])]. In nine structures, two different R22(8) motifs with either two N-H...O or two N-H...S hydrogen bonds can be observed [CASPUI (Hu et al., 2005[Hu, S.-L., Yin, G.-D. & Wu, A.-X. (2005). Acta Cryst. E61, o2408-o2409.]), GEMCAC (Read et al., 1988[Read, G., Randal, R., Hursthouse, M. B. & Short, R. (1988). J. Chem. Soc. Perkin Trans. 2, pp. 1103-1105.]), PABPAL (Chierotti et al., 2010[Chierotti, M. R., Ferrero, L., Garino, N., Gobetto, R., Pellegrino, L., Braga, D., Grepioni, F. & Maini, L. (2010). Chem. Eur. J. 16, 4347-4358.]), RAPNAY (Long et al., 2005[Long, T., Zhou, H.-B. & Wu, A.-X. (2005). Acta Cryst. E61, o2169-o2171.]), TURCIL01 (Tiekink, 1989[Tiekink, E. R. T. (1989). Z. Kristallogr. 187, 79.]), TURCIL02 (Munshi & Guru Row, 2006[Munshi, P. & Guru Row, T. N. (2006). Acta Cryst. B62, 612-626.]), UXIXUV (Ferreira et al., 2011[Ferreira, F. F., Trindade, A. C., Antonio, S. G., de, O. & Paiva-Santos, C. (2011). CrystEngComm, 13, 5474-5479.]), UXIXUV01 (Tutughamiarso & Egert, 2011[Tutughamiarso, M. & Egert, E. (2011). Acta Cryst. C67, o439-o445.]) and LANZIL (Al-Deeb et al., 2012[Al-Deeb, O. A., El-Emam, A. A., Al-Turkistani, A. A., Ng, S. W. & Tiekink, E. R. T. (2012). Acta Cryst. E68, o676-o677.])].

The CSD search also yielded the crystal structure of the monohydrate of (I) [CSD refcodes AMTURM (Swaminathan & Chacko, 1978[Swaminathan, S. & Chacko, K. K. (1978). Acta Cryst. B34, 3108-3110.]), AMTURM01 (Raper et al., 1985[Raper, E. S., Oughtred, R. E. & Nowell, I. W. (1985). Acta Cryst. C41, 758-760.]) and YEJKUV00 (Hützler & Bolte, 2012[Hützler, M. & Bolte, M. (2012). Private communication (CCDC number 902340). CCDC, Union Road, Cambridge, England.])], in which the molecules of (I) are connected by R21(6) motifs of N-H...O hydrogen bonds, building chains that are crosslinked via the water molecules, resulting in a three-dimensional network. Hydrogen bonds involving S atoms as an acceptor are only present between molecules of (I) and water (O-H...S).

In summary, the additional NH2 hydrogen-bond donor group at C6 (next to the N-H group) of 2-thiouracil seems to favour the formation of an R21(6) N-H...O hydrogen-bonding pattern since this motif is present in all crystal structures of (I). The S atom of (I) participates in hydrogen bonds exclusively in the presence of water which is the only incorporated solvent containing hydrogen-bond donor groups. In four pseudopolymorphs of (I), the formation of R22(8) dimers is observed. This is in agreement with the results of a CSD substructure search, which revealed the R22(8) motif to be the most frequent hydrogen-bond pattern in crystal structures of 2-thiouracil derivatives.

[Figure 1]
Figure 1
A perspective view of (Ia), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are shown as small spheres of arbitrary radii. The dashed lines indicate N-H...O hydrogen bonds.
[Figure 2]
Figure 2
A partial packing diagram for (Ia), with chains of (I) running parallel to [1[\overline{1}]0]. N-H...O hydrogen bonds are shown as dashed lines. [Symmetry code: (i) x - 1, y + 1, z.]
[Figure 3]
Figure 3
A perspective view of (Ib), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are shown as small spheres of arbitrary radii. The dashed lines indicate N-H...O hydrogen bonds. Only the major occupied site of the disordered DMAC molecule is shown.
[Figure 4]
Figure 4
A partial packing diagram for (Ib). N-H...O hydrogen bonds are shown as dashed lines. Only the major occupied site of the disordered DMAC molecule is shown. [Symmetry codes: (i) -x + 1, -y + 2, -z + 1; (ii) -x + [{1\over 2}], y + [{1\over 2}], -z + [{1\over 2}].]
[Figure 5]
Figure 5
A perspective view of (Ic), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are shown as small spheres of arbitrary radii. The dashed lines indicate N-H...O hydrogen bonds. DMAC molecules X and Y are disordered and only the major occupied sites are shown.
[Figure 6]
Figure 6
A perspective view of (Id), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are shown as small spheres of arbitrary radii. The dashed lines indicate N-H...O hydrogen bonds. Only the major occupied sites of disordered NMP molecules Y and Z are shown.
[Figure 7]
Figure 7
A partial packing diagram for (Ic). N-H...O hydrogen bonds are shown as dashed lines. DMAC molecule Y is not displayed. Only the major occupied site of disordered DMAC molecule X is shown. [Symmetry code: (i) x + [{1\over 2}], -y + 1, z.] A view of the packing of isomorphous compound (Id)[link] is available in the Supplementary materials.
[Figure 8]
Figure 8
A perspective view of (Ie), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are shown as small spheres of arbitrary radii. The dashed lines indicate N-H...O hydrogen bonds.
[Figure 9]
Figure 9
A partial packing diagram for (Ie). N-H...O hydrogen bonds are shown as dashed lines. NMP molecule Y is not displayed. [Symmetry code: (i) -x + [{1\over 2}], y - [{1\over 2}], z.]
[Figure 10]
Figure 10
A packing diagram for (Ie). N-H...O hydrogen bonds are shown as dashed lines.

Experimental

Solvent evaporation experiments with the commercially available monohydrate of 6-amino-2-thiouracil under different conditions yielded compounds (Ia)-(Ie) (see Table 1[link]). In order to optimize the crystallization process, further experiments at different temperatures and with varied crystallization rates were carried out. However, the crystal quality did not improve significantly.

Pseudopolymorph (Ia)[link]

Crystal data
  • C4H5N3OS·2C3H7NO

  • Mr = 289.36

  • Triclinic, [P \overline 1]

  • a = 8.0894 (16) Å

  • b = 12.037 (3) Å

  • c = 15.390 (3) Å

  • [alpha] = 89.774 (19)°

  • [beta] = 89.466 (17)°

  • [gamma] = 76.691 (17)°

  • V = 1458.2 (5) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.23 mm-1

  • T = 173 K

  • 0.30 × 0.15 × 0.10 mm

Data collection
  • Stoe IPDS II two-circle diffractometer

  • Absorption correction: multi-scan (X-AREA; Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.933, Tmax = 0.977

  • 11063 measured reflections

  • 5428 independent reflections

  • 1966 reflections with I > 2[sigma](I)

  • Rint = 0.105

Refinement
  • R[F2 > 2[sigma](F2)] = 0.077

  • wR(F2) = 0.199

  • S = 0.90

  • 5428 reflections

  • 351 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.21 e Å-3

  • [Delta][rho]min = -0.40 e Å-3

Table 2
Hydrogen-bond geometry (Å, °) for (Ia)[link]

D-H...A D-H H...A D...A D-H...A
N1A-H1A...O41B 0.88 1.76 2.601 (7) 160
N3A-H3A...O11X 0.88 1.88 2.756 (7) 170
N61A-H61A...O11W 0.88 1.96 2.834 (9) 172
N61A-H61B...O41B 0.88 2.20 2.929 (8) 140
N1B-H1B...O41Ai 0.88 1.78 2.620 (7) 159
N3B-H3B...O11Y 0.88 1.87 2.738 (9) 169
N61B-H61C...O11Z 0.88 1.96 2.840 (8) 174
N61B-H61D...O41Ai 0.88 2.21 2.937 (7) 140
Symmetry code: (i) x-1, y+1, z.

Pseudopolymorph (Ib)[link]

Crystal data
  • C4H5N3OS·C4H9NO

  • Mr = 230.29

  • Monoclinic, P 21 /n

  • a = 9.4615 (9) Å

  • b = 9.2679 (11) Å

  • c = 13.4208 (12) Å

  • [beta] = 101.801 (7)°

  • V = 1152.0 (2) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.27 mm-1

  • T = 173 K

  • 0.50 × 0.30 × 0.25 mm

Data collection
  • Stoe IPDS II two-circle diffractometer

  • Absorption correction: multi-scan (X-AREA; Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.877, Tmax = 0.936

  • 9565 measured reflections

  • 2163 independent reflections

  • 1968 reflections with I > 2[sigma](I)

  • Rint = 0.058

Refinement
  • R[F2 > 2[sigma](F2)] = 0.040

  • wR(F2) = 0.118

  • S = 1.07

  • 2163 reflections

  • 171 parameters

  • 132 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.24 e Å-3

  • [Delta][rho]min = -0.19 e Å-3

Table 3
Hydrogen-bond geometry (Å, °) for (Ib)[link]

D-H...A D-H H...A D...A D-H...A
N1A-H1A...O21X 0.88 (2) 1.94 (2) 2.743 (2) 151 (2)
N3A-H3A...O41Ai 0.89 (2) 1.90 (2) 2.7892 (19) 175 (2)
N61A-H61A...O21X 0.85 (2) 2.08 (2) 2.870 (2) 153 (2)
N61A-H62A...O41Aii 0.88 (2) 2.00 (2) 2.848 (2) 165 (2)
Symmetry codes: (i) -x+1, -y+2, -z+1; (ii) [-x+{\script{1\over 2}}, y-{\script{1\over 2}}, -z+{\script{1\over 2}}].

Pseudopolymorph (Ic)[link]

Crystal data
  • 2C4H5N3OS·3C4H9NO

  • Mr = 547.71

  • Orthorhombic, P c a 21

  • a = 15.2133 (7) Å

  • b = 7.4335 (13) Å

  • c = 24.445 (3) Å

  • V = 2764.4 (6) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.24 mm-1

  • T = 173 K

  • 0.27 × 0.20 × 0.15 mm

Data collection
  • Stoe IPDS II two-circle diffractometer

  • Absorption correction: multi-scan (X-AREA; Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.938, Tmax = 0.965

  • 33090 measured reflections

  • 5184 independent reflections

  • 3323 reflections with I > 2[sigma](I)

  • Rint = 0.149

Refinement
  • R[F2 > 2[sigma](F2)] = 0.063

  • wR(F2) = 0.113

  • S = 0.93

  • 5184 reflections

  • 378 parameters

  • 357 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.32 e Å-3

  • [Delta][rho]min = -0.23 e Å-3

  • Absolute structure: Flack (1983[Flack, H. D. (1983). Acta Cryst. A39, 876-881.]), 2517 Friedel pairs

  • Flack parameter: 0.04 (14)

Table 4
Hydrogen-bond geometry (Å, °) for (Ic)[link]

D-H...A D-H H...A D...A D-H...A
N1B-H1B...O21Z 0.88 1.90 2.718 (6) 155
N3B-H3B...O41A 0.88 1.95 2.823 (5) 173
N61B-H61B...O21Z 0.88 (2) 2.10 (4) 2.873 (7) 146 (5)
N61B-H62B...O21Y 0.87 (2) 2.02 (3) 2.830 (7) 155 (6)
N1A-H1A...O21X 0.88 1.94 2.761 (6) 156
N3A-H3A...O41B 0.88 1.92 2.792 (5) 172
N61A-H61A...O21X 0.89 (2) 2.18 (4) 2.922 (6) 140 (5)
N61A-H62A...O41Bi 0.87 (2) 2.08 (2) 2.937 (6) 171 (5)
Symmetry code: (i) [x+{\script{1\over 2}}, -y+1, z].

Pseudopolymorph (Id)[link]

Crystal data
  • 2C4H5N3OS·3C5H9NO

  • Mr = 583.74

  • Orthorhombic, P c a 21

  • a = 15.2293 (10) Å

  • b = 7.5483 (4) Å

  • c = 25.1871 (13) Å

  • V = 2895.4 (3) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.23 mm-1

  • T = 173 K

  • 0.34 × 0.28 × 0.16 mm

Data collection
  • Stoe IPDS II two-circle diffractometer

  • Absorption correction: multi-scan (X-AREA; Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.925, Tmax = 0.964

  • 8280 measured reflections

  • 4332 independent reflections

  • 3541 reflections with I > 2[sigma](I)

  • Rint = 0.053

Refinement
  • R[F2 > 2[sigma](F2)] = 0.062

  • wR(F2) = 0.170

  • S = 1.06

  • 4332 reflections

  • 474 parameters

  • 569 restraints

  • H-atom parameters constrained

  • [Delta][rho]max = 0.36 e Å-3

  • [Delta][rho]min = -0.34 e Å-3

  • Absolute structure: Flack (1983[Flack, H. D. (1983). Acta Cryst. A39, 876-881.]), 1810 Friedel pairs

  • Flack parameter: 0.12 (15)

Table 5
Hydrogen-bond geometry (Å, °) for (Id)[link]

D-H...A D-H H...A D...A D-H...A
N1A-H1A...O21X 0.88 1.94 2.760 (6) 155
N3A-H3A...O41B 0.88 1.85 2.724 (6) 172
N61A-H61B...O21X 0.88 2.14 2.912 (7) 146
N61A-H61A...O41Bi 0.88 1.98 2.847 (6) 170
N1B-H1B...O21Z 0.88 1.89 2.710 (7) 154
N3B-H3B...O41A 0.88 1.96 2.827 (6) 171
N61B-H61D...O21Z 0.88 2.08 2.844 (8) 144
N61B-H61C...O2Y' 0.88 1.91 2.70 (2) 149
N61B-H61C...O21Y 0.88 2.21 2.985 (14) 147
Symmetry code: (i) [x+{\script{1\over 2}}, -y+1, z].

Pseudopolymorph (Ie)[link]

Crystal data
  • 2C4H5N3OS·3C5H9NO

  • Mr = 583.74

  • Orthorhombic, P b c a

  • a = 7.5509 (7) Å

  • b = 15.2328 (12) Å

  • c = 50.601 (3) Å

  • V = 5820.2 (8) Å3

  • Z = 8

  • Mo K[alpha] radiation

  • [mu] = 0.23 mm-1

  • T = 173 K

  • 0.29 × 0.14 × 0.10 mm

Data collection
  • Stoe IPDS II two-circle diffractometer

  • Absorption correction: multi-scan (X-AREA; Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.936, Tmax = 0.977

  • 30686 measured reflections

  • 5484 independent reflections

  • 2211 reflections with I > 2[sigma](I)

  • Rint = 0.157

Refinement
  • R[F2 > 2[sigma](F2)] = 0.079

  • wR(F2) = 0.229

  • S = 0.90

  • 5484 reflections

  • 367 parameters

  • 352 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.83 e Å-3

  • [Delta][rho]min = -0.43 e Å-3

Table 6
Hydrogen-bond geometry (Å, °) for (Ie)[link]

D-H...A D-H H...A D...A D-H...A
N1B-H1B...O21Z 0.88 1.91 2.740 (6) 156
N3B-H3B...O41A 0.88 1.97 2.843 (6) 171
N61B-H61B...O21Y 0.87 (2) 2.11 (4) 2.904 (7) 152 (6)
N61B-H62B...O21Z 0.88 (2) 2.10 (3) 2.924 (7) 155 (6)
N1A-H1A...O21X 0.88 1.92 2.753 (6) 156
N3A-H3A...O41B 0.88 1.88 2.751 (6) 173
N61A-H61A...O21X 0.88 (2) 2.17 (4) 2.959 (6) 149 (6)
N61A-H62A...O41Bi 0.88 (2) 1.97 (2) 2.851 (6) 174 (6)
Symmetry code: (i) [-x+{\script{1\over 2}}, y-{\script{1\over 2}}, z].

Table 1
Crystallization of 6-amino-2-thiouracil.

Crystal 6-Amino-2-thiouracil Solvent Temperature
  monohydrate (mg, mmol)    
(Ia) 5.8, 0.036 DMF (270 µl) Room temperature
(Ib) 7.3, 0.045 DMF/DMAC (1:1 v/v, 75 µl) Room temperature
(Ic) 4.5, 0.028 DMAC (150 µl) Room temperature
(Id) 4.4, 0.027 NMP (50 µl) Room temperature
(Ie) 6.3, 0.039 NMP (110 µl) 277 K

All H atoms except those of the disordered solvent molecules were initially located by difference Fourier syntheses. Subsequently, all H atoms in (Ia) and (Id), the H atoms bonded to C atoms in (Ib), (Ic) and (Ie), and the H atoms of the imide groups in (Ic) and (Ie) were refined using a riding model, with methyl C-H = 0.98 Å, secondary C-H = 0.99 Å, aromatic C-H = 0.95 Å and N-H = 0.88 Å, and with Uiso(H) = 1.5Ueq(C) for methyl H atoms, 1.2Ueq(C) for secondary and aromatic H atoms, and 1.2Ueq(N). In (Ib), all H atoms bonded to N atoms were refined isotropically and the N-H bond lengths were restrained to 0.88 (2) Å. In (Ic) and (Ie), isotropic refinement of the H atoms of the amino groups resulted in isotropic displacement parameters smaller than the equivalent isotropic displacement parameters of the parent N atoms. Therefore, they were coupled to those of the N atoms, with Uiso(H) = 1.2Ueq(N), and the N-H distances were restrained to 0.88 (2) Å. For all methyl groups, except those of the disordered solvent molecules, free rotation about their local threefold axis was allowed.

The DMAC molecule in (Ib) and DMAC molecules X and Y in (Ic), respectively, show disorder over a pseudo-mirror plane along atoms O21(X/Y) and C32(X/Y) [site-occupation factor for the major occupied orientation = 0.629 (8) in (Ib), and 0.712 (11) for X and 0.630 (11) for Y in (Ic)].

In (Id), NMP molecules Y and Z show disorder over a pseudo-mirror plane, respectively [site-occupation factor for the major occupied orientation = 0.600 (14) for Y and 0.688 (11) for Z]. In molecule Y, the pseudo-mirror plane intersects the N1Y-C2Y and C4Y-C5Y bonds; thus, all atom positions are different for both orientations. In molecule Z, the pseudo-mirror plane intersects O21Z and the N1Y-C2Y and C4Y-C5Y bonds; hence, the positions of O21Z coincide in both orientations.

Similarity restraints for the 1,2 and 1,3 distances were applied for all solvent molecules in (Ib), (Id) and (Ie) and for solvent molecules X and Y in (Ic).

The isotropic restraint (ISOR; Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]), similar-ADP restraint (SIMU) and rigid-bond restraint (DELU) were applied for all solvent molecules in (Ie) and for disordered DMAC molecules X and Y in (Ic). In (Id), SIMU and DELU were applied for disordered NMP molecules Y and Z.

For all pseudopolymorphs, data collection: X-AREA (Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]); cell refinement: X-AREA; data reduction: X-AREA; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: Mercury (Macrae et al., 2008[Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.]) and XP in SHELXTL-Plus (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: publCIF (Westrip, 2010[Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.]).


Supplementary data for this paper are available from the IUCr electronic archives (Reference: FG3285 ). Services for accessing these data are described at the back of the journal.


Acknowledgements

The authors thank Professor Dr Ernst Egert for helpful discussions.

References

Abu-Hashem, A. A. & Youssef, M. M. (2011). Molecules, 16, 1956-1972.  [ChemPort] [PubMed]
Alagarsamy, V., Vijayakumar, S. & Solomon, V. R. (2007). Biomed. Pharmacother. 61, 285-291.  [CrossRef] [PubMed] [ChemPort]
Al-Deeb, O. A., El-Emam, A. A., Al-Turkistani, A. A., Ng, S. W. & Tiekink, E. R. T. (2012). Acta Cryst. E68, o676-o677.  [CSD] [CrossRef] [details]
Allen, F. H. (2002). Acta Cryst. B58, 380-388.  [ISI] [CrossRef] [details]
Antoniadis, C. D., Corban, G. J., Hadjikakou, S. K., Hadjiliadis, N., Kubicki, M., Warner, S. & Butler, I. S. (2003). Eur. J. Inorg. Chem. pp. 1635-1640.  [CSD] [CrossRef]
Balas, V. I., Verginadis, I. I., Geromichalos, G. D., Kourkoumelis, N., Male, L., Hursthouse, M. B., Repana, K. H., Yiannaki, E., Charalabopoulos, K., Bakas, T. & Hadjikakou, S. K. (2011). Eur. J. Med. Chem. 46, 2835-2844.  [ISI] [CSD] [CrossRef] [ChemPort] [PubMed]
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.  [CrossRef] [ChemPort] [ISI]
Brewer, A. D., Ferguson, G. & Parvez, M. (1987). Acta Cryst. C43, 144-147.  [CrossRef] [details]
Chierotti, M. R., Ferrero, L., Garino, N., Gobetto, R., Pellegrino, L., Braga, D., Grepioni, F. & Maini, L. (2010). Chem. Eur. J. 16, 4347-4358.  [CSD] [CrossRef] [ChemPort] [PubMed]
Cosimelli, B., Greco, G., Ehlardo, M., Novellino, E., Da Settimo, F., Taliani, S., La Motta, C., Bellandi, M., Tuccinardi, T., Martinelli, A., Ciampi, O., Trincavelli, M. L. & Martini, C. (2008). J. Med. Chem. 51, 1764-1770.  [ISI] [CrossRef] [PubMed] [ChemPort]
Delage, C., H'Naifi, A. & Goursolle, M. (1986). C. R. Seances Acad. Sci. Ser. II, 303, 1645.
Delage, C., H'Naifi, A., Goursolle, M. & Carpy, A. (1986). C. R. Seances Acad. Sci. Ser. II, 302, 219.
El-Gazzar, A.-R. B. A. & Hafez, H. N. (2009). Bioorg. Med. Chem. 19, 3392-3397.  [ChemPort]
Ferreira, F. F., Trindade, A. C., Antonio, S. G., de, O. & Paiva-Santos, C. (2011). CrystEngComm, 13, 5474-5479.  [ISI] [CSD] [CrossRef] [ChemPort]
Flack, H. D. (1983). Acta Cryst. A39, 876-881.  [CrossRef] [details]
Fonar, M. S., Simonov, Y. A., Ganin, E. V., Yavolovskii, A. A. & Lyuboradzki, R. (1999). Kristallografiya (Russ.) (Crystallogr. Rep.), 44, 1076.
Hu, S.-L., Yin, G.-D. & Wu, A.-X. (2005). Acta Cryst. E61, o2408-o2409.  [CSD] [CrossRef] [details]
Hützler, M. & Bolte, M. (2012). Private communication (CCDC number 902340). CCDC, Union Road, Cambridge, England.
Ivanova, B. B. & Spiteller, M. (2010). Cryst. Growth Des. 10, 2470-2474.  [CSD] [CrossRef] [ChemPort]
Kubicki, M., Owczarzak, A., Balas, V. I. & Hadjikakou, S. K. (2012). J. Coord. Chem. 65, 1107-1117.  [ISI] [CSD] [CrossRef] [ChemPort]
Long, T., Zhou, H.-B. & Wu, A.-X. (2005). Acta Cryst. E61, o2169-o2171.  [CSD] [CrossRef] [details]
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.  [ISI] [CrossRef] [ChemPort] [details]
Matkovic-Calogovic, D., Besic, E. & Sankovic, K. (2002). Acta Cryst. C58, o568-o569.  [CSD] [CrossRef] [details]
Medda, F., Russell, R. J. M., Higgins, M., McCarthy, A. R., Campbell, J., Slawin, A. M. Z., Lane, D. P., Lain, Y. & Westwood, N. J. (2009). J. Med. Chem. 52, 2673-2682.  [ISI] [CSD] [CrossRef] [PubMed] [ChemPort]
Mohamed, N. R., El-Saidi, M. M. T., Alia, Y. M. & Elnagdib, M. H. (2007). Bioorg. Med. Chem. 15, 6227-6235.  [CrossRef] [PubMed] [ChemPort]
Munshi, P. & Guru Row, T. N. (2006). Acta Cryst. B62, 612-626.  [ISI] [CSD] [CrossRef] [details]
Orzeszko, B., Kazimierczuk, Z., Maurin, J. K., Laudy, A. E., Starosciak, B. J., Vilpo, J., Vilpo, L., Balzarini, J. & Orzeszko, A. (2004). Il Farmaco, 59, 929-937.  [CSD] [CrossRef] [PubMed] [ChemPort]
Pastor, A., Alajarin, R., Vaquero, J. J., Alvarez-Builla, J., Fau de Casa-Juana, M., Sunkel, C., Priego, J. G., Fonseca, I. & Sanz-Aparicio, J. (1994). Tetrahedron, 50, 8085-8098.  [CrossRef] [ChemPort] [ISI]
Raper, E. S., Oughtred, R. E. & Nowell, I. W. (1985). Acta Cryst. C41, 758-760.  [CrossRef] [details]
Read, G., Randal, R., Hursthouse, M. B. & Short, R. (1988). J. Chem. Soc. Perkin Trans. 2, pp. 1103-1105.
Romero, M. A., Sanchez, M. P., Quiros, M., Sanchez, F., Salas, J. M., Moreno, M. N. & Faure, R. (1993). Can. J. Chem. 71, 29-33.  [CrossRef] [ChemPort] [ISI]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.
Swaminathan, S. & Chacko, K. K. (1978). Acta Cryst. B34, 3108-3110.  [CrossRef] [details] [ISI]
Tadros, A. B. & Abd El Nabey, B. A. (2000). Anti-Corros. Methods Mater. 47, 211-214.  [CrossRef] [ChemPort]
Tashkhodzhaev, B., Turgunov, K. K., Usmanova, B., Averkiev, B. B., Antipin, Y. M. & Shakhidoyatov, K. M. (2002). Zh. Strukt. Khim. (Russ. J. Struct. Chem.), 43, 944.
Tiekink, E. R. T. (1989). Z. Kristallogr. 187, 79.  [CrossRef]
Tiekink, E. R. T. (2001). Z. Kristallogr. 216, 122.  [CrossRef]
Tutughamiarso, M. & Egert, E. (2011). Acta Cryst. C67, o439-o445.  [CSD] [CrossRef] [details]
Van Hecke, K., Nockemann, P. & Van Meervelt, L. (2005). Z. Kristallogr. 220, 155.
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.  [ISI] [CrossRef] [ChemPort] [details]
Wright, G. E. & Brown, N. C. (1976). Biochim. Biophys. Acta, 432, 37-48.  [ChemPort] [PubMed] [ISI]
Youssif, S. & Mohamed, S. F. (2008). Chem. Monthly, 139, 161-168.  [CrossRef] [ChemPort]


Acta Cryst (2013). C69, 93-100   [ doi:10.1107/S010827011204930X ]